000 01277 a2200373 4500
005 20250511174105.0
264 0 _c19760510
008 197605s 0 0 eng d
022 _a0027-8874
024 7 _a10.1093/jnci/56.1.89
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNicolin, A
245 0 0 _aAntigenic changes of L5178Y lymphoma after treatment with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide in vivo.
_h[electronic resource]
260 _bJournal of the National Cancer Institute
_cJan 1976
300 _a89-93 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntigens, Neoplasm
650 0 4 _aCarmustine
_xtherapeutic use
650 0 4 _aImmunization
650 0 4 _aImmunization, Passive
650 0 4 _aImmunosuppression Therapy
650 0 4 _aLeukemia, Experimental
_xdrug therapy
650 0 4 _aLymphocytes
_ximmunology
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aRadiation Effects
650 0 4 _aTriazenes
_xpharmacology
700 1 _aSpreafico, F
700 1 _aBonmassar, E
700 1 _aGoldin, A
773 0 _tJournal of the National Cancer Institute
_gvol. 56
_gno. 1
_gp. 89-93
856 4 0 _uhttps://doi.org/10.1093/jnci/56.1.89
_zAvailable from publisher's website
999 _c1262290
_d1262290